CORPORATE GOVERNANCE
Dialysis Corporation of America has a tradition and processes
to adhere to rigorous standards of ethics and integrity in
its operations, the conduct of its management, and in its
disclosure and reporting of its operations to shareholders
and the investment community, particularly the reliability
of our financial information. In 2002, the Sarbanes-Oxley
Act of 2002 (the "Act") became law. The Act, among
many other focuses, created or changed a number of corporate
governance rules that affect boards of directors, created
the Public Company Accounting Oversight Board (PCAOB), a quasi-governmental
board responsible for regulating accounting firms that audit
public companies, provided for the maintenance of disclosure
controls and procedures, and enhanced the integrity and reliability
of financial information available to shareholders and investors.
The Act is much broader in scope and required rulemaking initiatives
of the Securities and Exchange Commission ("SEC")
and self-regulatory organizations ("SROs"), including
the Nasdaq Stock Market ("Nasdaq"), which association
provides the trading market, The Nasdaq Global Market, for
our shares which trade under the symbol "DCAI."
The Act and the SROs established new rules and regulations
to:
- strengthen the independence of accounting firms that
are auditing public companies
- improve the quality and transparency of financial statements
and corporate disclosure
- enhance corporate governance
- strengthen enforcement of the federal securities laws
The Act and new rules and regulations of the SEC and the
Nasdaq are very extensive, and this is only a brief introduction
to the Corporate Governance Prescriptions.
For matters relating to our directors and their independence,
the capacities of our Audit, Compensation and Nominating Committees,
their functions and Charters, which each Committee has, please
continue further.
Our operative principle is to deal with each other, our
patients, shareholders and the communities within which we
operate with honesty, fairness, dignity and respect. We attempt
to conduct our business operations and affairs with the highest
ethical standards. We have adopted and operate under a Code
of Ethics and Business Conduct, which applies to all our personnel,
including our principal executive and financial officers.
To view and or print our Code of
Ethics and Insider
Trading Policy, please click on the link. If you prefer
to have a copy mailed to you, please contact our corporate
secretary, Joshua M. Jaffe at:
email: jmj@jaffefakllc.com
fax: (201) 288-8208
telephone: (201) 288-8282
|
